Cure My Disease

Don't miss your cure!

 Log in / Sign up

Massive asian TAVR registry aims to unlock secrets of long-term valve success.

NCT ID NCT07709858

Recruiting now Knowledge-focused Sponsor: Eunpyeong St. Mary's Hospital Source: ClinicalTrials.gov ↗

First seen Jul 17, 2026 · Last updated Jul 17, 2026

Summary

This study is a large registry that collects data from thousands of patients across Asia who have undergone transcatheter aortic valve replacement (TAVR) for severe aortic stenosis. Researchers will analyze medical records to see how well the valves perform over time and what factors influence outcomes like survival and complications. No extra tests or visits are required—it simply looks at existing information from routine care.

What this could mean

Our plain-language read of the trial. This is informational only — not medical advice or a prediction.

Active substance
transcatheter aortic valve replacement (TAVR) procedure
What this could lead to
If successful, this registry could identify best practices and factors that improve long-term survival and reduce complications after TAVR.
What could go wrong
As an observational registry, it cannot prove cause and effect. Results may be influenced by differences in patient care across centers.

This is an AI summary of the original study and may miss details. Read our disclaimer.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for AORTIC VALVE STENOSIS are added.

Our safety recommendation!

By submitting, you agree to our Terms of use

Conditions

The condition(s) this trial relates to.

aortic valve stenosis

As listed by the trial registrant

The condition terms exactly as the trial's registrant entered them.

AORTIC VALVE STENOSIS TRANSCATHETER AORTIC VALVE REPLACEMENT (TAVR)

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • The Catholic University of Korea, Eunpyeong St. Mary's Hospital

    RECRUITING

    Seoul, 03312, South Korea

    Contact Email: •••••@•••••

    Contact Phone: •••-•••-•••• Email: •••••@•••••

    Contact

More trials for these conditions

Other studies related to the condition(s) this trial covers.